Filing Details

Accession Number:
0002001011-24-000067
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-08-09 17:52:17
Reporting Period:
2024-08-08
Accepted Time:
2024-08-09 17:52:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
886163 Ligand Pharmaceuticals Inc LGND Pharmaceutical Preparations (2834) 770160744
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1392029 C Todd Davis 555 Heritage Drive
Suite 200
Jupiter FL 33458
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-08-08 2,500 $97.39 123,010 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct